Charles Schwab Investment Management Inc Graybug Vision, Inc. Transaction History

Charles Schwab Investment Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 16, 2021	SELL	$3.18 - $5.17 $74,513 - $121,143	-23,432 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$3.53 - $6.1 $45,660 - $78,903	-12,935 Reduced 35.57%	23,432 $128,000
Q1 2021 May 17, 2021	SELL	$5.55 - $35.0 $15,318 - $96,600	-2,760 Reduced 7.05%	36,367 $202,000
Q4 2020 Feb 16, 2021	BUY	$13.05 - $33.93 $510,607 - $1.33 Million	39,127 New	39,127 $1.14 Million

Ticker GRAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,517,700
Market Cap $63.5M
Description
Graybug Vision, Inc., a clinical-stage biopharmaceutical company, focuses on the development of medicines for the treatment of diseases of the retina and optic nerve. The company's lead product candidate is GB-102, an intravitreal injection of a microparticle depot formulation of sunitinib that is in Phase I/IIa and IIb clinical trials for the t...

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Management Inc with notifications on news.